Strides Pharma Science Limited — Important, 10-07-2025: General Updates

Strides Pharma Science Limited has announced a board meeting to consider the financial results for the quarter and half-year. The Board has proposed a final dividend of Rs. 4 per share for FY 2024-25, subject to shareholder approval. Dividend payments will be subject to tax deduction at source (TDS) as per applicable rates for different shareholder categories. Shareholders are advised to update their PAN, bank, and contact details with the Registrar or Depository Participants to ensure correct TDS deduction and seamless dividend credit.